Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of MS patients in relapse and remission

From: Restoration of regulatory B cell deficiency following alemtuzumab therapy in patients with relapsing multiple sclerosis

Characteristic MS relapse MS remission
Age (years, mean ± SD) 34.5 ± 9.4 36.9 ± 5.2
Women:men (n:n) 16:4 10:7
Onset age (years, mean ± SD) 30.4 ± 22.0 29.8 ± 7.3
Disease duration (years, mean ± SD) 12 ± 24.9 6 ± 5.9
EDSS (mean ± SD) 2.9 ± 1.9 1.8 ± 1.9